UNIGE document Scientific Article
previous document  unige:92640  next document
add to browser collection
Title

Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy

Authors
Kovacs, Gabor G
Ferrer, Isidro
Grinberg, Lea T
Alafuzoff, Irina
Attems, Johannes
Budka, Herbert
Cairns, Nigel J
Crary, John F
show hidden authors show all authors [1 - 72]
Published in Acta Neuropathologica. 2016, vol. 131, no. 1, p. 87-102
Abstract Pathological accumulation of abnormally phosphorylated tau protein in astrocytes is a frequent, but poorly characterized feature of the aging brain. Its etiology is uncertain, but its presence is sufficiently ubiquitous to merit further characterization and classification, which may stimulate clinicopathological studies and research into its pathobiology. This paper aims to harmonize evaluation and nomenclature of aging-related tau astrogliopathy (ARTAG), a term that refers to a morphological spectrum of astroglial pathology detected by tau immunohistochemistry, especially with phosphorylation-dependent and 4R isoform-specific antibodies. ARTAG occurs mainly, but not exclusively, in individuals over 60 years of age. Tau-immunoreactive astrocytes in ARTAG include thorn-shaped astrocytes at the glia limitans and in white matter, as well as solitary or clustered astrocytes with perinuclear cytoplasmic tau immunoreactivity that extends into the astroglial processes as fine fibrillar or granular immunopositivity, typically in gray matter. Various forms of ARTAG may coexist in the same brain and might reflect different pathogenic processes. Based on morphology and anatomical distribution, ARTAG can be distinguished from primary tauopathies, but may be concurrent with primary tauopathies or other disorders. We recommend four steps for evaluation of ARTAG: (1) identification of five types based on the location of either morphologies of tau astrogliopathy: subpial, subependymal, perivascular, white matter, gray matter; (2) documentation of the regional involvement: medial temporal lobe, lobar (frontal, parietal, occipital, lateral temporal), subcortical, brainstem; (3) documentation of the severity of tau astrogliopathy; and (4) description of subregional involvement. Some types of ARTAG may underlie neurological symptoms; however, the clinical significance of ARTAG is currently uncertain and awaits further studies. The goal of this proposal is to raise awareness of astroglial tau pathology in the aged brain, facilitating communication among neuropathologists and researchers, and informing interpretation of clinical biomarkers and imaging studies that focus on tau-related indicators.
Keywords AgingAnimalsAstrocytes/cytologyBrain/metabolism/pathologyHumansNeuroglia/pathologyTauopathies/metabolism/pathologytau Proteins/metabolism
Identifiers
PMID: 26659578
Full text
Article (Published version) (3 MB) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Neuroimagerie moléculaire en psychiatrie (983)
Citation
(ISO format)
KOVACS, Gabor G et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. In: Acta Neuropathologica, 2016, vol. 131, n° 1, p. 87-102. https://archive-ouverte.unige.ch/unige:92640

29 hits

0 download

Update

Deposited on : 2017-03-16

Export document
Format :
Citation style :